Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases
- Written by PR Newswire
- Research presented today by University of Michigan Medical School highlights FT011's ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data
- The research demonstrated that treatment with FT011 results in a remarkable reversal in the activation of genetic markers associated...
